Kerry Rogers, MD, received her medical degree from the Rosalind Franklin University of Medicine and Science in Chicago, IL. After this she completed an internship and a residency in internal medicine at the University of Michigan in Ann Arbor, MI, followed by a fellowship in hematology and oncology at The Ohio State University in Columbus, OH.
Dr Rogers now serves as an Assistant Professor in the Department of Hematology at The James Cancer Hospital and Solove Research Institute at The Ohio State University in Columbus, OH, where she is also a member of the Leukemia Research Program. Dr Rogers is the author of several journal articles and has been published in Leukemia and Cancer Cell.
Speaking on novel therapeutics for autoimmune cytopenias
Dr Rogers’ research is focused in the field of developing novel therapeutics for autoimmune cytopenias. In particular, her research group focuses on optimization of the use of BTK inhibitors, studying resistance, combination therapies and treatment discontinuation. Dr Rogers is also the principal investigator on multiple clinical trials.